Allogene Therapeutics
ALLO
#8751
Rank
โ‚น20.15 B
Marketcap
โ‚น58.16
Share price
-5.88%
Change (1 day)
-47.22%
Change (1 year)

Earnings for Allogene Therapeutics (ALLO)

Earnings in 2026 (TTM): -โ‚น15.08 Billion

According to Allogene Therapeutics 's latest financial reports the company's current earnings are โ‚น4.64 Million. In 2025 the company made an earning of -โ‚น17.59 Billion, an increase over its 2024 earnings that were of -โ‚น23.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allogene Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น15.08 Billion-14.28%
2025 -โ‚น17.59 Billion-26.13%
2024 -โ‚น23.82 Billion-18.12%
2023 -โ‚น29.09 Billion-6.44%
2022 -โ‚น31.09 Billion31.14%
2021 -โ‚น23.71 Billion2.23%
2020 -โ‚น23.19 Billion25.98%
2019 -โ‚น18.41 Billion-4.68%
2018 -โ‚น19.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion-4.91%๐Ÿ‡บ๐Ÿ‡ธ USA